Patent Law and Generics: How Patents Protect Innovation in Pharmaceuticals
January 23, 2026 by Maxwell Harrington
Patent law protects pharmaceutical innovation by granting temporary monopolies, but the Hatch-Waxman Act balances this with generic access. Generics save billions annually, while patent strategies like evergreening and pay-for-delay delay affordability.
Patent Term Restoration: How Pharmaceutical Companies Legally Extend Drug Exclusivity
January 4, 2026 by Maxwell Harrington
Patent term restoration lets pharmaceutical companies recover time lost during FDA approval, extending drug exclusivity by up to five years. Learn how the Hatch-Waxman Act works, who qualifies, and why it's critical for drug innovation.
Recent Patent Cases and Generic Delays: 2023-2025 Examples
December 15, 2025 by Maxwell Harrington
Between 2023 and 2025, patent lawsuits have become the main reason generic drugs are approved but never reach pharmacies. Patients pay thousands more each month while brand companies extend monopolies through legal tactics.